Moderna Inc (MRNA)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -4,714,000 | 8,362,000 | 12,202,000 | -747,000 | -514,000 |
| Revenue | US$ in thousands | 6,775,000 | 19,263,000 | 18,471,000 | 803,000 | 60,000 |
| Net profit margin | -69.58% | 43.41% | 66.06% | -93.03% | -856.67% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-4,714,000K ÷ $6,775,000K
= -69.58%
Based on the data provided for Moderna Inc's net profit margin over the past five years, there have been significant fluctuations in the company's profitability. In 2023, the net profit margin was reported at -68.84%, indicating that the company's expenses exceeded its revenues, resulting in a negative profit margin. This was a stark contrast to the previous year, 2022, when the net profit margin was relatively healthy at 43.41%.
In 2021, Moderna Inc showed a robust net profit margin of 66.06%, reflecting strong profitability and efficient cost management. However, this was preceded by a drastic decrease in profitability in 2020, with a net profit margin of -92.99%, suggesting significant losses compared to revenue.
The most notable observation is the exceptionally low net profit margin of -853.73% in 2019, which indicates substantial losses far exceeding revenue. This could be attributed to various factors such as high expenses, one-time charges, or significant write-offs that impacted the company's bottom line that year.
Overall, the fluctuations in Moderna Inc's net profit margin over the five-year period highlight the company's varying financial performance and emphasize the importance of closely monitoring profitability metrics to gauge its financial health and stability.
Peer comparison
Dec 31, 2023